Medpace Holdings EBITDA Margin 2014-2024 | MEDP

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Medpace Holdings (MEDP) over the last 10 years. The current EBITDA margin for Medpace Holdings as of September 30, 2024 is .
Medpace Holdings EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $2.07B $0.44B 21.11%
2024-06-30 $2.03B $0.41B 20.16%
2024-03-31 $1.96B $0.38B 19.47%
2023-12-31 $1.89B $0.36B 19.26%
2023-09-30 $1.78B $0.35B 19.71%
2023-06-30 $1.67B $0.34B 20.50%
2023-03-31 $1.56B $0.32B 20.73%
2022-12-31 $1.46B $0.30B 20.62%
2022-09-30 $1.38B $0.28B 20.36%
2022-06-30 $1.29B $0.26B 19.81%
2022-03-31 $1.21B $0.24B 19.52%
2021-12-31 $1.14B $0.22B 19.34%
2021-09-30 $1.09B $0.22B 20.11%
2021-06-30 $1.03B $0.21B 20.62%
2021-03-31 $0.96B $0.20B 20.84%
2020-12-31 $0.93B $0.19B 20.09%
2020-09-30 $0.90B $0.17B 18.64%
2020-06-30 $0.88B $0.15B 17.12%
2020-03-31 $0.89B $0.16B 17.62%
2019-12-31 $0.86B $0.15B 17.54%
2019-09-30 $0.82B $0.15B 18.23%
2019-06-30 $0.79B $0.15B 18.45%
2019-03-31 $0.74B $0.14B 18.46%
2018-12-31 $0.70B $0.13B 18.89%
2018-09-30 $0.63B $0.11B 17.76%
2018-06-30 $0.56B $0.11B 19.75%
2018-03-31 $0.49B $0.11B 21.30%
2017-12-31 $0.44B $0.10B 23.57%
2017-09-30 $0.43B $0.11B 26.16%
2017-06-30 $0.43B $0.11B 26.11%
2017-03-31 $0.43B $0.11B 26.34%
2016-12-31 $0.42B $0.11B 26.78%
2016-06-30 $0.30B $0.06B 21.48%
Sector Industry Market Cap Revenue
Medical Medical Services $10.202B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00